Picture of Mersana Therapeutics logo

MRSN — Mersana Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Mersana Therapeutics Q3 EPS USD -0.35

Nov 07 (Reuters) - Mersana Therapeutics Q3 collaboration revenue USD 7.698
million.
* Q3 net income USD -41.656 million

Recent news on Mersana Therapeutics

See all news